In a trial of WEGOVY injection in adult patients with type 2 diabetes and body mass index (BMI) greater than or equal to 27 kg/m 2 for weight reduction (Study 3), hypoglycemia (defined as a plasma glucose less than 54 mg/dL) was reported in more patients treated with WEGOVY versus placebo [see Adverse Reactions (6.1)]
Weight loss will likely begin within the first month and remain gradual for the next several months, especially when paired with a healthy diet and exercise
How it works : Every plan begins with an in-office consultation, tailored dosing, and ongoing support for a sustainable, science-backed way to feel your best
Ask your PBM for a net cost comparison of each reference drug plus rebate against the available biosimilar net price
Unlike many compounds, synthetic peptides like retatrutide fall outside the scope of ICH Q3A guidelines on impurities in new drug substances, necessitating specialized handling and compliance protocols
Andhere we go, and in borderline diabetics who could use some blood sugar spike suppression